No ‘one size fits all’ treatment approach for neovascular AMD

Researchers at the virtual American Society of Retina Specialists meeting reported a positive and clinically meaningful link between the number of anti-VEGF injections and change in visual acuity in patients with neovascular age-related macular degeneration.
However, there was no ‘one-size-fits-all’ approach to treating neovascular AMD therapy and advised considering the impact of treatment burden on patients, according to the presentation.
“When analyzing anti-VEGF agents in general, more injections have yielded better vision; however, this does come at the cost of a high

Full Story →